Healthcare101

  The global point-of-care diagnostics market is expected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion in 2023, at a CAGR of 9.4% from 2023 to 2028. Key Growth Influencing Factors: Technological Advancements Expansion of Test Menu Personalized Medicine and Precision Diagnostics Integration with Telehealth and Remote Monitoring Point-of-Care Testing in Non-Traditional Settings Regulatory Landscape and Quality Assurance Point-of-Care Diagnostics in Global Health Initiatives Data Analytics and Artificial Intelligence (AI) Point-of-Care Diagnostics in Home Healthcare Collaboration and Partnerships To know about the assumptions considered for the study download the pdf brochure Technological Advancements: Continued advancements in technology, including miniaturization, automation, and connectivity, will drive innovation in point-of-care diagnostic devices. Emerging technologies such as microfluidics, lab-on-a-chip, and smartphone-based diagnostics will enable rap...

  Point of Care Diagnostics Market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. Globally, the growing burden of chronic diseases like diabetes, cardiovascular diseases, cancer is accelerating the demand for  rapid and effective diagnostic testing. Moreover, the rising advancements in microfluidic technology, and miniaturization are enabling manufacturers to develop portable and smaller PoC diagnostics device. Moreover, the shift towards healthcare decentralization and increasing investments for product development is anticipated to bolster the growth opportunity for point of care diagnostics market. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 Browse in-depth TOC on "Point of Care Diagnostics Market" 191 - Tables 51 - Figures 322 – Pages The Lateral Flo...

 According to the new market research report published by MarketsandMarkets, " Point of Care Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027", the global point of care diagnostics market in terms of revenue was estimated to be worth $45.4 billion in 2022 and is poised to reach $75.5 billion by 2027, growing at a CAGR of 10.7% from 2022 to 2027. Browse in-depth TOC on "Point of Care Diagnostics Industry" 334 - Tables 48 - Figures 398 – Pages ​ Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The high prevalence of diabetes, cardiovascular diseases, infectious diseases and other target conditions, the increased number of CLIA-waived POC tests, increased focus of players in strengthening the POCT product portfolio, initiatives by government to boos...

According to the new market research report published by MarketsandMarkets, " Point of Care Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027", the global point of care diagnostics market in terms of revenue was estimated to be worth $45.4 billion in 2022 and is poised to reach $75.5 billion by 2027, growing at a CAGR of 10.7% from 2022 to 2027. Browse in-depth TOC on "Point of Care Diagnostics Industry" 334 - Tables 48 - Figures 398 – Pages. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The high prevalence of diabetes, cardiovascular diseases, infectious diseases and other target conditions, the increased number of CLIA-waived POC tests, increased focus of players in strengthening the POCT product portfolio, initiatives by governme...

 The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. The growth of the global Point of Care diagnostics market can be attributed to factors such as increasing prevalence of respiratory diseases (such as COVID-19 and influenza) across the globe, and improved access to point-of-care devices through online platforms are some of the other key factors likely to drive the long-term growth of the point-of-care diagnostics market. Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185 Key Players: Abbott Laboratories (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), Nova Biomedi...